Welspun Specialty Solutions logo

Welspun Specialty Solutions CEO, MD, chairman, board of directors and AGM

NSE: WELSPLSOLBSE: 500365Industrial ProductsSmall Cap

Last close ₹43.12down ₹0.76 (1.73%)BSE ₹43.01

Share price at the NSE close on 23 Oct 2026. Previous close ₹43.88.

52-week range of BSE trades to 23 Oct 2026
₹31.00Low, 30 Mar 2026₹63.29High, 18 Jun 2026
Market cap
₹2,857 Cr1,026th largest listed
P/E
198.1
P/B
6.2
Dividend yield
Nonein the last 12 months
ROE
3.2%
ROCE
5.1%
Debt to equity
0.00
Volume, NSE
10,72,95835.7% delivered

Welspun Specialty Solutions board of directors

At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • ChairpersonBalkrishan Gopiram GoenkaRelated to the promoter
  • Chief executiveAnuj Burakia
  • Company Secretary and Compliance OfficerDipti Modi

8 directors4 independent1 executive3 non-executive

  • Balkrishan Gopiram Goenka · ChairpersonNon-executive · joined Aug 2018 · reappointed Apr 2024 · 4 listed boards
  • Anuj Burakia · Chief executiveExecutive · joined May 2015 · reappointed Jul 2024 · 1 listed board · 1 committee seat
  • Prakashmal TatiaNon-executive · joined Aug 2018 · reappointed Sep 2023 · 1 listed board · 1 committee seat
  • Vipul MathurNon-executive · joined Apr 2022 · 2 listed boards · 1 committee seat
  • Amita MisraIndependent · joined Apr 2022 · reappointed Apr 2026 · 53 months as independent · 2 listed boards · 2 as independent · 3 committee seats, 1 as chair
  • Viswanathan Hariharan KollengodeIndependent · joined Apr 2022 · reappointed Apr 2026 · 53 months as independent · 1 listed board · 1 as independent · 4 committee seats, 2 as chair
  • Ravindra PandeyIndependent · joined Nov 2024 · reappointed Nov 2024 · 22 months as independent · 3 listed boards · 3 as independent · 7 committee seats, 1 as chair
  • Anil Kumar JhaIndependent · joined Aug 2026 · reappointed Aug 2026 · 1 month as independent · 2 listed boards · 2 as independent · 2 committee seats, 1 as chair

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

2 directors who left
  • Narayana Rao Myneni, left 27 Aug 2026: Tenure Completion
  • Dipali Sheth, left 23 Nov 2024: Others

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 21 Jul 20268 of 8 present4 independent · 81 days in between
    • 30 Apr 20268 of 8 present4 independent · 23 days in between
    • 6 Apr 20266 of 8 present3 independent
  • Audit Committee

    Chair Viswanathan Hariharan Kollengode

    Amita Misra, Prakashmal Tatia

    • 21 Jul 20263 of 3 present3 independent · 7 days in between
    • 13 Jul 20263 of 3 present3 independent · 73 days in between
    • 30 Apr 20263 of 3 present3 independent · 9 days in between
    • 20 Apr 20263 of 3 present3 independent
  • Nomination and remuneration committee

    Chair Viswanathan Hariharan Kollengode

    Amita Misra, Prakashmal Tatia

    • 23 Sep 20263 of 3 present2 independent · 63 days in between
    • 21 Jul 20262 of 3 present2 independent · 81 days in between
    • 30 Apr 20262 of 3 present2 independent
  • Stakeholders Relationship Committee

    Chair Viswanathan Hariharan Kollengode

    Amita Misra, Anuj Burakia

    • 13 Jul 20263 of 3 present2 independent · 32 days in between
    • 10 Jun 20262 of 3 present2 independent
  • Risk Management Committee

    Chair Viswanathan Hariharan Kollengode

    Amita Misra, Anuj Burakia, Navin Agarwal, Anil Kumar Jha

    • 10 Jun 20263 of 4 present3 independent
  • Corporate Social Responsibility Committee

    Chair Viswanathan Hariharan Kollengode

    Anuj Burakia, Prakashmal Tatia

    • 10 Jun 20262 of 3 present2 independent

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Mar 2026.

  • BSR & CO LLPPeer-review certificate valid to Jul 2028
1 earlier auditor
  • B S R & Co LLPNamed in the filing for the quarter to Mar 2025

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved

Open at the quarter's end

At most 1 complaint open, quarter to Dec 2025.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
Yes
The chair is related to the managing director
No
The filing has a part on fines and penalties
No
The filing has a part on tax disputes
No
There was a cyber security incident in the quarter
No

The company's own answers in its filing.

How money raised was used

Reported for the quarter to Jun 2025. The company's results filing for the quarter to Sep 2026 says no statement of how money raised was used applies to it. A warrant or partly paid issue plans the whole issue while the money comes in over time, so the amount set aside can be more than raised so far.

RaisedAmount raisedForSet asideSpentSpent elsewhereReason and comments
Rights IssuesMar 2025, checked by Care Ratings Limited349.86Repayment or prepayment, in full or in part, of certain borrowings availed by the Company284.00284.00NoAudit committee: No Comments by Audit CommitteeAuditors: No Comments by Auditors
Rights IssuesMar 2025, checked by Care Ratings Limited349.86General Corporate Purposes63.5663.56NoAudit committee: No Comments by Audit CommitteeAuditors: No Comments by Auditors
Rights IssuesMar 2025, checked by Care Ratings Limited349.86Issue related expenses2.292.29NoAudit committee: No Comments by Audit CommitteeAuditors: No Comments by Auditors
₹ crore. Checked by is the agency appointed to monitor how the money is used. The reason and the comments are the company's, its audit committee's and its auditors' own words.